Safety and Tolerability Study of Cogane™ in Healthy Volunteers and Parkinson's Disease Patients
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Phytopharm plc is developing Cogane™ which is a new medicine for the treatment of Parkinson's
disease (PD). The purpose of the study is to find out if Cogane is safe and well tolerated in
both healthy volunteers and Parkinson's disease patients and to determine if there is a
difference in the way that the body deals with Cogane (pharmacokinetics) between these two
groups.
It is expected that the study will prove that Cogane™ is safe and well tolerated and will
provide us with a pharmacokinetic profile for both subject groups.